Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Decitabine and guadecitabine are hypomethylating agents (HMAs) that exert inhibitory effects against cancer cells. This includes stimulation of anti-tumor immunity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients. Treatment of AML and MDS patients with the HMAs confers up...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Kah Keng, Hassan, Rosline, Yaacob, Nik Soriani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947882/
https://www.ncbi.nlm.nih.gov/pubmed/33718188
http://dx.doi.org/10.3389/fonc.2021.624742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947882/
https://www.ncbi.nlm.nih.gov/pubmed/33718188
http://dx.doi.org/10.3389/fonc.2021.624742

Ejemplares similares